# TEST_STRATEGY.md  
NeuroGrid MedIntel  
Version: 1.0  
Status: Execution-Ready  
Classification: Internal – Engineering, QA, Compliance  

---

## 1. PURPOSE

This document defines the **formal, execution-ready testing strategy** for NeuroGrid MedIntel.  
It ensures system reliability, safety, regulatory compliance, and operational integrity across all layers of the platform, including AI inference, data pipelines, security boundaries, and decentralized components.

This document applies to **production, pre-production, and regulated environments**.

---

## 2. SCOPE

This strategy governs testing for:

- AI/ML models (training, inference, drift, bias)
- Medical data ingestion and normalization
- Clinical decision-support outputs
- Security, privacy, and cryptographic enforcement
- Blockchain and decentralized components (where applicable)
- API and integration boundaries
- Infrastructure, scalability, and resilience
- Regulatory compliance readiness (LGPD, HIPAA-aligned principles, ANVISA guidance)

Out of scope:
- Consumer UX testing
- Marketing systems
- Non-clinical experimental prototypes

---

## 3. TESTING PRINCIPLES

1. **Safety First** – No model or feature may enter production without validated safety thresholds.
2. **Regulatory Traceability** – Every test must map to a documented requirement.
3. **Defense-in-Depth** – Multiple testing layers prevent single-point failure.
4. **Deterministic Validation** – AI outputs must be reproducible under controlled conditions.
5. **Fail-Safe Design** – Failure modes must default to safe, non-decision states.

---

## 4. TESTING LEVELS

### 4.1 Unit Testing

**Objective:** Verify correctness of individual components.

Coverage includes:
- Data parsers
- Feature extractors
- Model input validators
- Rule-based decision logic
- Cryptographic utilities

Requirements:
- ≥ 90% code coverage for critical modules
- All clinical logic units require explicit test cases
- Automated execution on every commit

---

### 4.2 Integration Testing

**Objective:** Validate interactions between system components.

Includes:
- AI model + inference pipeline
- Data ingestion + normalization
- API gateway + downstream services
- Blockchain write/read cycles (if enabled)

Key checks:
- Schema compatibility
- Latency boundaries
- Error propagation integrity
- Secure token handling

---

### 4.3 System Testing

**Objective:** Validate full system behavior under real-world conditions.

Scenarios:
- End-to-end diagnostic request
- Multi-source data ingestion
- Model inference with confidence scoring
- Failover and rollback behavior

Success criteria:
- Deterministic output for identical inputs
- Safe degradation under failure
- No unauthorized data exposure

---

### 4.4 AI/ML-Specific Testing

#### 4.4.1 Model Validation
- Accuracy, precision, recall, AUROC
- Calibration curves
- Confidence threshold enforcement

#### 4.4.2 Bias & Fairness Testing
- Stratified evaluation by demographic proxies
- Distributional parity analysis
- Alert generation for bias deviation

#### 4.4.3 Drift Detection
- Input data drift
- Prediction drift
- Confidence score drift

Automated retraining **must not** occur without human validation.

---

### 4.5 Security Testing

Includes:
- Static Application Security Testing (SAST)
- Dynamic Application Security Testing (DAST)
- Penetration testing
- Cryptographic validation

Mandatory checks:
- Encryption at rest and in transit
- Key rotation enforcement
- Access control boundary testing
- Zero-trust assumptions

---

### 4.6 Privacy & Compliance Testing

Validated against:
- LGPD principles
- HIPAA-aligned safeguards
- ANVISA medical software guidance

Tests include:
- Data minimization verification
- Consent enforcement
- Data deletion irreversibility
- Audit trail immutability

---

### 4.7 Performance & Load Testing

Objectives:
- Validate scalability
- Ensure deterministic latency

Benchmarks:
- Inference latency thresholds
- Concurrent request handling
- Stress and soak testing
- Resource exhaustion behavior

---

### 4.8 Resilience & Failure Testing

Scenarios:
- Network partition
- Model service outage
- Corrupted input data
- Blockchain unavailability

Expected behavior:
- Graceful degradation
- Safe fallback responses
- Alert generation
- No unsafe clinical output

---

## 5. TEST ENVIRONMENTS

| Environment | Purpose |
|------------|--------|
| Local | Developer validation |
| CI | Automated regression |
| Staging | Regulatory-aligned testing |
| Pre-Prod | Final release validation |
| Production | Monitoring & post-deploy checks |

Production testing is **read-only** and observational.

---

## 6. TEST DATA MANAGEMENT

Rules:
- No real patient data in non-production environments
- Synthetic or anonymized datasets only
- Dataset provenance must be documented
- Test data lifecycle must include secure destruction

---

## 7. AUTOMATION STRATEGY

Automated:
- Unit tests
- Integration tests
- Regression suites
- Security scans
- Drift detection

Manual:
- Clinical output review
- Regulatory acceptance testing
- Ethical risk review

Automation failures **block deployment**.

---

## 8. TRACEABILITY MATRIX

Each test case must map to:
- Functional requirement
- Safety requirement
- Compliance requirement

Traceability artifacts are mandatory for:
- Regulatory audits
- Incident investigation
- Model versioning

---

## 9. DEFECT MANAGEMENT

Severity classification:
- **Critical:** Patient safety or data breach risk
- **High:** Clinical reliability impact
- **Medium:** Operational degradation
- **Low:** Non-blocking defect

Critical defects trigger:
- Immediate deployment halt
- Incident response protocol
- Executive notification

---

## 10. RELEASE CRITERIA

A release is approved only if:
- All critical and high defects resolved
- Compliance checks passed
- AI validation metrics within bounds
- Security tests clean
- Executive technical sign-off completed

---

## 11. POST-DEPLOY MONITORING

Continuous monitoring includes:
- Model performance metrics
- Drift alerts
- Security anomalies
- Regulatory compliance signals

Post-deploy rollback must be executable within defined SLA.

---

## 12. OWNERSHIP & GOVERNANCE

| Role | Responsibility |
|----|---------------|
| Engineering | Test execution |
| ML Lead | Model validation |
| Security | Threat testing |
| Compliance | Regulatory alignment |
| Executive | Final approval |

---

## 13. CHANGE CONTROL

Any modification to this strategy requires:
- Version increment
- Change rationale
- Risk assessment
- Executive approval

---

## 14. FINAL NOTE

NeuroGrid MedIntel testing is **not optional**, **not advisory**, and **not best-effort**.  
It is a **core safety and governance function** of the platform.

Failure to comply invalidates production eligibility.

---
END OF DOCUMENT

